Control of uracil synthesis by arginine in Escherichia coli. J. Bacteriol. 87:1436 Bacteriol. 87: -1442 Bacteriol. 87: . 1964 .-It is shown that arginine affects uracil biosynthesis in Escherichia coli. The effect of arginine on uracil synthesis was analyzed by following the changes in the level of aspartate transcarbamylase, the first specific enzyme in uracil synthesis. In this research, an effect of arginine on aspartate transcarbamylase formation was observed only if the bacteria were preincubated with arginine in the presence of uracil analogues that cause apparent partial derepression of this enzyme. The possible effect of a structural modification of aspartate transcarbamylase by 2-thiouracil, the analogue principally used, is considered. However, it is shown that arginine causes derepression of aspartate transcarbamylase, even if a modification of the enzyme occurs. An effect of uracil on arginine synthesis can also be observed in repressible strains of E. coli, if conditions of partial derepression of the enzymes involved in arginine synthesis prevail. However, neither the derepression of aspartate transcarbamylase by arginine nor the derepression of ornithine transcarbamylase by uracil is accompanied by changes in the level of carbamyl phosphokinase, the enzyme that catalyzes carbamyl phosphate synthesis.
The biosynthetic sequences of arginine and uracil are connected through a common intermediate, carbamyl phosphate: It has been shown that each sequence is controlled by its end product, or a derivative of the end product, through feedback inhibition and enzyme repression. The investigations of Gorini and Maas (1958) and Vogel (1961) showed that arginine represses all the enzymes that are specifically concerned with its own biosynthesis, and inhibits the first reaction in the biosynthetic pathway (Ennis and Gorini, 1961) .
In the pyrimidine sequence, Yates and Pardee (1957) showed enzyme repression by uracil of all the enzymes involved in pyrimidine biosynthesis. Cytidine triphosphate was shown to specifically inhibit aspartate transearbamylase (ATC), the enzyme responsible for carbamylation of aspartic acid (Gerhardt and Pardee, 1962) .
The question arises whether these control mechanisms constitute the only regulatory devices for arginine and uracil biosynthesis, or whether an additional mechanism regulating the formation of the common intermediate, carbamyl phosphate exists.
Recent investigations have shown that control of a common intermediate of divergent pathways can be achieved by enzyme multiplicity. Thus, Stadtman et al. (1961) presented evidence that, in the biosynthesis of lysine, methionine, and threonine, three different aspartokinases catalyze the formation of the common intermediate aspartyl phosphate. The activity and synthesis of these enzymes were shown to be regulated by different end products.
In addition to enzyme multiplicity, "multivalent repression" may constitute an alternative device for control of a common intermediate. In "multivalent repression," an enzyme can only be repressed by the joint action of all, or several, of the end products (Freundlich, Burns, and Umbarger, 1962) .
The question arises whether these same control mechanisms operate in carbamyl phosphate synthesis. Recent investigations by Gorini and Kalman (1963) showed that uracil represses the formation of carbamyl phosphokinase (CPK). In the light of the considerations given above, an effect of arginine on carbamyl phosphate synthesis might also be expected.
The present study reveals that arginine indeed affects uracil biosynthesis. However, the mechanism by which arginine exerts this effect is still obscure.
MATERIALS Jones, Spector, and Lipmann (1955) by measuring citrulline synthesis from carbamyl phosphate and ornithine. Citrulline was analyzed as described by Oginsky (1957) . Assay mixtures contained (in a total volume of 1 ml): 10 jAmoles of L-ornithine, 10 ,umoles of dilithium carbamyl phosphate, 5 ,umoles of MgCl2, 20 ,umoles of tris buffer, and a rate-limiting amount of cell extract.
ATC activity was measured by carbamyl aspartic acid synthesis from carbamyl phosphate and aspartic acid according to Ravel, Hunter, and Shive (1959) . Carbamyl aspartic acid was determined according to Koritz and Cohen (1954) . Assay mixtures at pH 7.0 (phosphate) and 8.5 (tris) consisted of 30 j,moles of buffer, 20 j,moles of L-aspartic acid, 10 j,moles of dilithium carbamyl phosphate, and a rate-limiting amount of cell extract. The total volume of the assay mixture was 1 ml.
CPK was assayed by following formation of carbamyl phosphate from adenosine triphosphate (ATP) and ammonium carbonate by citrulline synthesis (Jones, 1962 2-thiouracil or arginine alone retained their viability. The effect of arginine was found to be specific; neither ornithine nor any other amino acid affected 2-thiouracil action in bacteria.
To elucidate whether a control process that coordinates pyrimidine and arginine synthesis might be affected in the presence of 2-thiouracil and arginine, a study of the changes in the level of the enz_Vmes required for pyrimidine and arginine synthesis under different growth conditions was undertaken.
Effect on ATC and OTC formation. In the experiments to be reported, ATC was chosen to represent an enzyme in pyrimidine biosynthesis, and OTC was chosen as a representative enzyme for arginine biosynthesis. The effect of preincubation with 2-thiouracil in the presence and absence of arginine on the formation of these enzymes, in the arginine-repressible strains E. coli M-39 A-23 and E. coli W and in the arginine nonrepressible strains of E. coli B, was studied. In all experiments, bacteria in the logarithmic phase of growth were used. A typical experiment is described in Table 1. Derepression of ATC by 2-thiouracil occurred in all the strains tested. Derepression by 2-thiouracil can readily be explained, if we assume that the analogue inhibits a reaction leading to the synthesis of uracil, thus causing depletion of endogenous uracil and consequent derepression of ATC.
The effect of 2-thiouracil on the in vitro activity of crude ATC, dihydroorotase, dihydroorotic acid dehydrogenase, and partially purified yeast orotidylic acid decarboxylase and orotidylic acid pyrophosphorylase was examined, but no inhibition of enzyme activity could thus far be demonstrated (Zamir and Ben-Ishai, unpublished data) . It is, however, feasible that a derivative of 2-thiouracil may inhibit an enzyme in the uracil pathway.
Arginine, though without effect by itself, increases the level of ATC in the presence of 2-thiouracil. A 20-fold increase in the level of the enzyme is observed in the ornithine-, citrulline-, and arginine-requiring mutant E. coli M-39 A-23 and a 6-to 7-fold increase in E. coli W and B; 2-thiouracil alone causes only a 2-to 3-fold increase in the level of the enzyme.
The mechanism by which arginine augments the partial derepression of ATC caused by 2-thiouracil, and the reason that the effect on ATC formation by arginine is not observed in the absence of 2-thiouracil, may find an explanation in the results obtained with OTC.
Both uracil and 2-thiouracil cause a two-to threefold increase in the level of OTC in the strains repressible by arginine, but have no effect in the nonrepressible strains. Similar results were recently obtained by Gorini and Kalman (1963) . The possibility exists that uracil, and perhaps also 2-thiouracil, inhibit a reaction leading to arginine synthesis, thus causing depletion of arginine and consequent derepression of OTC.
In E. coli W, addition of exogenous arginine causes repression of OTC, whereas addition of exogenous uracil does not cause repression of ATC, suggesting that sufficient endogenous uracil is available in these cells for maximal repression. Uracil affected the level of OTC only in the absence of arginine, namely when OTC synthesis was partially derepressed.
It is reasonable to assume that arginine may also affect the level of ATC only when the latter is partially derepressed, as in the presence of 2-thiouracil. If so, the effect of arginine on uracil synthesis should be observable whenever endogenous uracil can be partially depleted. Therefore, another analogue, 6-azauracil was tried. Azauridylic acid is known to inhibit uracil synthesis by inhibition of orotidylic acid decarboxylase (Handschumacher, 1960) . At concentrations of 6-azauracil that cause partial derepression of ATC, arginine increased the level of the enzyme twofold ( Beckwith et al. (1962) , who found that analogues may cause structural changes in the enzyme protein that affect its specific activity. Thus, Beckwith et al. (1962) were able to demonstrate that ATC formed in the presence of 2-thiouracil was less sensitive to inhibition by cytidine than was ATC formed in the absence of the analogue. The ratio of activity at pH 7.0:8.4 decreased from 12 in the control to 0.73 in 2-thiouracil-treated bacteria.
These findings aroused the suspicion that the derepression of ATC observed after incubation with 2-thiouracil might be due to formation of modified ATC. To test this possibility, the ac- (Table 4) show that the ratio of enzyme activity at pH 7.0:8.5 is, in fact, changed as a result of preincubation with 2-thiouracil; furthermore, decreased sensitivity to cytidine was also observed, suggesting the formation of unnatural ATC. These results do not exclude the possibility of a genuine derepression being superimposed upon unnatural enzyme formation.
In the presence of arginine, the same changed ratio is obtained; however, the absolute levels of ATC increased threefold, compared with 2-thiouracil alone, independently of whether enzyme activity was tested at pH 7.0 or 8.5. These results In the present study, this derepression was achieved with the aid of the uracil analogues, 2-thiouracil and 6-azauracil. The use of analogues, however, greatly complicates the interpretation of the results, because modified enzyme proteins with changed specific activities may be formed as a result of analogue incorporation into RNA.
In the specific case of ATC, a modified form of the enzyme is formed in the presence of 2-thiouracil. From the results obtained, it is impossible to decide what part of the increased activity of ATC is due to derepression and what part is due to modified enzyme formation.
The possibility that 2-thiouracil causes true derepression and formation of a naturally occurring ATC with properties of the presumed "modified" enzyme can, at present, not be excluded.
Partial derepression of the enzymes involved in pyrimidine biosynthesis should, however, also be obtainable in the absence of analogues. While we were making an attempt to obtain depletion of uracil in different strains of E. coli, Gorini and Kalman (1963) reported the isolation of a mutant of E. coli K12 in which uracil caused an absolute requirement for arginine. This mutant, grown on basal medium, exhibits full derepression of OTC and partial derepression of ATC. In the light of our findings that the effect of arginine on uracil synthesis can only be observed under partial derepression, added arginine should have such an effect in this mutant. A consideration of the data reported by these investigators, indeed, reveals that growth of the mutant in the presence of arginine causes a threefold derepression of ATC (Table 1 ; Gorini and Kalman, 1963) .
From the investigations on control mechanisms in divergent pathways, a control by arginine and uracil of carbamyl phosphate synthesis would be expected. If we assume that two carbamyl phosphokinases, one under exclusive control of arginine and one under exclusive control of uracil, exist, the derepression of OTC by uracil and ATC by arginine could not be explained, because arginine could not control uracil, and uracil could not control arginine synthesis.
To account for the mutual interference between arginine and uracil synthesis, one might postulate, however, that only a single carbamyl phosphokinase exists in E. coli and that this enzyme is controlled by arginine or uracil, or both. According to this model, addition of one end product should repress carbamyl phosphate synthesis and, consequently, inhibit not only its own synthesis but also the formation of the second end product. This, indeed, had been found with E. coli strain U28 (Gorini and Kalman, 1963) and E. coli R185-A (Novick and Maas, 1961) , where excess uracil inhibits growth of the organism, as a result of inadequate arginine synthesis. On the other hand, excess arginine would be expected to retard growth due to depletion of uracil. This paper deals with such an effect of arginine. The only other case we were able to find where such an effect has been observed was reported by Davis (1961) , who found that, in Neurospora, arginine restored a pyrimidine requirement when the suppressor mutant pyr 3-a-s is grown in the presence of this amino acid.
However, the interference between arginine and uracil synthesis is very limited in wild strains of E. coli. Moreover, these interferences are not accompanied by repression of CPK (Table 3) .
To account for the observed interferences in the wild as well as in the mutant strains, one could postulate that carbamyl phosphate synthesis may be mediated in E. coli by one arginine-repressible and one uracil-repressible carbamyl phosphokinase (CPK-A and CPK-U) that are subject to reciprocative feedback inhibition. Thus, CPK-A would be expected to be inhibited by uracil, and CPK-U by arginine.
The drastic interferences observed in the mutant strains might well be due to the fact that the mutations involved impaired utilization of carbamyl phosphate, owing to a deficiency of one of the two CPK.
The repression of CPK by uracil, on the one hand, and derepression of ATC by arginine in E. coli U28, on the other hand, could be explained if one assumes that this mutant possesses only the uracil-repressible CPK, which is subject to feedback inhibition by arginine.
In E. coli W, the effect of arginine on ATC and of uracil on OTC does not seem to be due to repression of the two postulated carbamyl phosphokinases, because these enzymes are already fully repressed when the wild strain is grown on basal medium. If one assumes inhibition of CPK-U and CPK-A by arginine and uracil, respectively, the observed derepression of ATC and OTC in the wild strain can, however, be explained.
The hypothesis presented requires partial inhibition of CPK activity by either end product. If certain mutants are, indeed, deficient in one carbamyl phosphokinase, inhibition by the end product of the other pathway should be particularly pronounced. This point is now under investigation.
